OQROGet OQRO Pro
Insider trade

Roivant Sciences (ROIV)Director sold ~$17.2M

Daniel Allen Gold, Director at Roivant Sciences, sold ~$17.2M of Roivant Sciences shares.

~$17.2M
Approx. value · 850K sh @ $20.25
18.5M
Holds after · shares reported
Traded
Nov 19, 2025
Filed
Nov 22, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Sep 19, 2025Insider · Their largest sale since 2022CEO sold ~$10.2M of ROIV shares in the open market
  2. Sep 22, 2025Insider · 1 personInsiders: 2 sales (~$6.2M)
  3. Sep 23, 2025InsiderCEO sold ~$9.06M of ROIV shares in the open market
  4. Oct 6, 2025InsiderCEO sold ~$2.8M of ROIV shares in the open market
  5. Oct 7, 2025InsiderCEO sold ~$5.74M of ROIV shares in the open market
  6. Oct 8, 2025InsiderCEO sold ~$2.25M of ROIV shares in the open market
  7. Oct 9, 2025InsiderCEO sold ~$1.71M of ROIV shares in the open market
  8. Oct 13, 2025InsiderCEO sold ~$337K of ROIV shares in the open market
  9. Oct 15, 2025InsiderCEO sold ~$7.02M of ROIV shares in the open market
  10. Oct 16, 2025InsiderCEO sold ~$5.43M of ROIV shares in the open market
  11. Oct 17, 2025InsiderCEO sold ~$2.02M of ROIV shares in the open market
  12. Oct 30, 2025Congress · 1 personMembers of Congress: 1 purchase, 1 sale
  13. Oct 31, 2025CongressDisclosed sale of ROIV — reported range $1,001 - $15,000
  14. Nov 7, 2025InsiderCEO sold ~$4.04M of ROIV shares in the open market
  15. Nov 10, 2025Company filing · Form 8-K · ResultsReported its results
  16. Nov 13, 2025Insider10% owner sold ~$5.98M of ROIV shares in the open market
  17. Nov 14, 2025Insider10% owner sold ~$20.9M of ROIV shares in the open market
  18. Nov 17, 2025Insider10% owner sold ~$11.1M of ROIV shares in the open market
  19. Nov 19, 2025 · this disclosureInsiderDirector sold ~$17.2M of ROIV shares in the open market

What came next

  1. Nov 19, 2025Insider · 3 peopleInsiders: 11 sales (~$61.7M)
  2. Dec 9, 2025InsiderCEO sold ~$4.17M of ROIV shares in the open market
  3. Dec 11, 2025Insider10% owner sold ~$16.8M of ROIV shares in the open market
  4. Dec 12, 2025Insider · Their largest sale since 202310% owner sold ~$43.4M of ROIV shares in the open market
  5. Dec 15, 2025Insider · 2 peopleInsiders: 4 sales (~$45.5M)
  6. Dec 16, 2025Insider · 3 peopleInsiders: 6 sales (~$63.4M)
  7. Dec 17, 2025Insider · 4 peopleInsiders: 10 sales (~$54.4M)
  8. Dec 23, 2025Insider · 2 peopleInsiders: 3 sales (~$13.6M)
  9. Dec 24, 2025InsiderCEO sold ~$1.69M of ROIV shares in the open market
  10. Dec 29, 2025InsiderDirector sold ~$6.78M of ROIV shares in the open market
  11. Dec 31, 2025Insider · Their largest sale since 2024Director sold ~$22.1M of ROIV shares in the open market
  12. Jan 12, 2026InsiderCEO sold ~$4.38M of ROIV shares in the open market
  13. Feb 6, 2026Company filing · Form 8-K · ResultsReported its results
  14. Feb 9, 2026InsiderDirector sold ~$8.99M of ROIV shares in the open market
  15. Feb 11, 2026Insider · 3 peopleInsiders: 3 sales (~$34.0M)
  16. Feb 12, 2026Insider · 3 peopleInsiders: 6 sales (~$34.1M)
  17. Feb 13, 2026Insider · 4 peopleInsiders: 7 sales (~$35.2M)
  18. Feb 19, 2026InsiderChair sold ~$38.4M of ROIV shares in the open market
  19. Feb 20, 2026InsiderChair sold ~$27.5M of ROIV shares in the open market
  20. Mar 3, 2026Company filing · Form 8-K · Material agreement, Reg FDSigned an important agreement, and shared information with investors (and 1 more item)
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Roivant Sciences

For Roivant Sciences, OQRO holds 18 insider filings (SEC Form 4 or Form 144) and 10 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its ROIV page.

Other recent filings by Daniel Allen Gold, Director

The full history of Daniel Allen Gold, Director is on the profile page.

How this filing works

Other disclosures at Roivant Sciences

Everything OQRO holds on this company is on its ROIV page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data